Cumberland Pharmaceuticals (CPIX) Cash from Operations (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) reported Cash from Operations of 387025.0 for Q1 2026, down 90.07% on a YoY basis from 3898517.0 in Q1 2025, and up 12698.45% sequentially from 3024.0 in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Cash from Operations (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 17 years of Cash from Operations data on file, last reported at 387025.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 90.07% year-over-year to 387025.0; the trailing twelve-month figure through Mar 2026 stood at 1421030.0 (down 73.8% YoY), and the FY2025 full-year result was 4932522.0, up 905.72% from the prior year.
- Cash from Operations climbed to 387025.0 in Q1 2026, from 3024.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 5235361.0 in Q2 2023 to a low of 2136647.0 in Q1 2024.
- A 5-year average of 1132622.24 and a median of 843801.0 in 2025 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations plunged 842.34% in 2023 and soared 282.46% in 2025, its largest moves.
- Tracing CPIX's Cash from Operations over 5 years: stood at 3638031.0 in 2022, then slumped by 71.41% to 1040121.0 in 2023, then soared by 83.12% to 1904618.0 in 2024, then plunged by 99.84% to 3024.0 in 2025, then soared by 12698.45% to 387025.0 in 2026.
- Business Quant data shows CPIX's Cash from Operations at 387025.0 in Q1 2026, 3024.0 in Q4 2025, and 187180.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn | 387,025.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 387,025.00 |
| Mar 31, 2026 | 387,025.00 |
| Dec 31, 2025 | 3,024.00 |
| Dec 31, 2025 | 3,024.00 |
| Sep 30, 2025 | 187,180.00 |
| Sep 30, 2025 | 187,180.00 |
| Jun 30, 2025 | 843,801.00 |
| Jun 30, 2025 | 843,801.00 |
| Mar 31, 2025 | 3.90 Mn |
| Mar 31, 2025 | 3.90 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Sep 30, 2024 | 475,503.00 |
| Sep 30, 2024 | 475,503.00 |
| Jun 30, 2024 | -855,660.00 |
| Jun 30, 2024 | -855,660.00 |
| Mar 31, 2024 | -2.14 Mn |
| Mar 31, 2024 | -2.14 Mn |
| Dec 31, 2023 | 1.04 Mn |
| Dec 31, 2023 | 1.04 Mn |